Optimizing invasive strategies for necrotizing pancreatitis: A Bayesian network analysis of randomized controlled trials
This review and network meta-analysis suggests that DSU and EDL may be promising options for treating necrotizing pancreatitis, though current evidence is inconclusive. Given varying risks, especially with DVS, treatment should be tailored to individual cases. More high-quality RCTs are needed to strengthen the evidence and guide practice.
Authors
- Nian Wu (ORCID: https://orcid.org/0000-0001-5656-5703)
- Zhiwei Wang (ORCID: https://orcid.org/0000-0001-6817-1242)
- Hua Liu (ORCID: https://orcid.org/0009-0009-1266-3585)
- Fanfan Yu
- Lu Huan
Institutions
- Pancreatic Cancer Action Network (US)
- First People's Hospital of Chongqing (CN)
- S.P.E.C.I.E.S. (US)
Publication Details
- Journal
- Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1097/md.0000000000042512
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00